Truist Securities Initiates Coverage On Lumexa Imaging Hldgs with Buy Rating, Announces Price Target of $18
Benzinga Newsdesk 4 weeks ago
Analyst RatingsNewsInitiationPrice Target
Truist Securities analyst Clarke Murphy initiates coverage on Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Buy rating and announces Price Target of $18.
Truist Securities analyst Clarke Murphy initiates coverage on Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Buy rating and announces Price Target of $18.